Shares of International Biotechnology (LON:IBT – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 721.28 and traded as high as GBX 978.41. International Biotechnology shares last traded at GBX 970, with a volume of 109,612 shares.
International Biotechnology Trading Down 0.8%
The company has a fifty day moving average of GBX 863.44 and a 200-day moving average of GBX 721.28. The company has a market capitalization of £309.55 million, a price-to-earnings ratio of -294.92 and a beta of 0.21.
International Biotechnology (LON:IBT – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported GBX (11.42) earnings per share (EPS) for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. As a group, equities research analysts expect that International Biotechnology will post 0.9435943 EPS for the current year.
International Biotechnology Company Profile
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Read More
- Five stocks we like better than International Biotechnology
- Using the MarketBeat Stock Split Calculator
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- What Does a Stock Split Mean?
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
